CGNX vs CLBT: fair value comparison
Cognex Corporation and Cellebrite DI Ltd. · Updated 2026-08-31
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Technology, CGNX currently sits closer to the top of our discount ranking.
| CGNX | CLBT | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $67.44 | $15.07 |
| 12-month range | $36.82–$71.31 | $13.35–$18.50 |
| Sector rank | #72 of 199 Technology | #76 of 199 Technology |
| Quality grade | A | A |
| Leverage | Low | Low |
| Margin trend | Stable | Stable |
| Revenue growth | Modest | Strong |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Uptrend | Mixed |
| DCF cross-check | Overvalued | Overvalued |
| 52-week position | The top quarter | The lower-middle quarter |
Full single-stock breakdowns: CGNX fair value analysis · CLBT fair value analysis